From a talk given at the UK launch of the new Type 2 treatment given by Viggo Birch, vice president and managing director, Novo Nordisk

From a talk given by Professor Anthony Barnett (Professor of Medicine and Honorary Consultant Physician at the University of Birmingham and Heart Of England NHS